Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Randomized, Open Label Study to Compare the Safety and Efficacy of Lixisenatide vs. Sulfonylurea on Top of Basal Insulin Treatment in Type 2 Diabetes Mellitus Subjects Who Elect to Fast During Ramadan

NCT02941367 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02941367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02941367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Randomized, Open Label Study to Compare the Safety and Efficacy of Lixisenatide vs. Sulfonylurea on Top of Basal Insulin Treatment in Type 2 Diabetes Mellitus Subjects Who Elect to Fast During Ramadan
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
February 23, 2017
Completion date
August 4, 2017
Enrollment
184 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2